glp-1 and eating disorder RAs in Disorders: Promising or Perilous? Eating Disorder Treatment Centers -

Quick Answer: Headache is a recognised side effect of GLP-1 receptor agonists, classified as common (1 in 10 to 1 in 100 people) for diabetes formulations and very common (more than 1 in 10) for weight-management doses

Living with complex chronic conditions like Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), mast cell activation syndrome (MCAS), and dysautonomia often feels like navigating a labyrinth without a map

Particularly high concentrations are found in skeletal muscle (around 80 % of all L-carnitine) and in the heart muscle

It is important to note that these mechanisms remain theoretical and are based largely on preclinical research

Possible reactions noted in the available literature include headache, mild gastrointestinal discomfort, difficulty sleeping, or mood changes